Since August 2018, all financial flows for clinical research and innovation have been brought together in one entity: the Fund for Innovation and Clinical Research. This replaces, among other things, the Platform for Digital Medicine and New Medical Technologies, the Clinical Research Fund (KOF), and the ‘speerpunt’ funding. Combining different financial flows for innovation and scientific research in a single fund will increase transparency and prevent competition and inefficient funding.
The Fund for Innovation and Clinical Research finances so-called type I projects. Clinical staff of the Ghent University Hospital who are involved in patient care in the broadest sense of the word, who want to carry out scientific research and who want to complete a PhD in Medical Sciences within the maximum project duration of four years, can submit an application for funding. This funding amounts to €50,000 per year (index 2008) for a maximum period of 4 years and is mainly intended as a partial exemption from the normal clinical activities.
Besides type I projects, there are also type II projects. These projects are distinguished by their sustainable academic and possibly also economic/social importance, occupy an international leading position, and are preferably, but not exclusively, multidisciplinary in nature. Clinical staff of the Ghent University Hospital who are involved in patient care in the broadest sense, and who want to develop groundbreaking, state-of-the-art diagnostic, therapeutic or digital processes, can submit an application for project financing. The allocated funding amounts to a maximum of €100,000 per year (index 2018) for a maximum period of 4 years. The call for type II projects also includes more limited innovative or research projects, with a high-risk profile, for which seeding funding can be requested for an amount between €20,000 – €70,000 maximum.
The call for type I projects of 2019 has already been completed. A new call will follow in the course of 2020. The call for type II project of 2019 will be announced shortly.
In order to be eligible for funding for a type I or II project, a series of criteria must be met. An application can be submitted if an application for external financing has already been made for the project (= non-UZ Gent financing such as FWO, BOF, KCE, Kom Op Tegen Kanker,…) and has been refused. As a candidate, it is necessary to first consult with the Health Innovation and Research Institute (HIRUZ) in order to assess the admissibility of your application. They also provide support to increase the chances of success and see if the potential project is not better funded in another way.
Read the extensive project call on the intranet page of the Fund for Innovation and Clinical Research. You will also find all the necessary documentation there.
Health Innovation and Research Institute (HIRUZ):
Dr. Sanne D’hondt: Sanne.Dhondt@UZGent.be
Fund for Innovation and Clinical Research:
Prof. Dr. Johan Decruyenaere (chair): Fonds.Innovatie.Onderzoek@UZGent.be